Advertisement

Topics

BioLineRx Announces Regulatory Submission of Phase 3 Registrational Study for BL-8040 in Stem ...

07:00 EDT 21 Aug 2017 | BioMedReports - Blog

The Phase 3 GENESIS trial is aimed at evaluating the safety, tolerability and efficacy of the combination treatment of BL-8040 and granulocyte colony-stimulating factor (G-CSF), as

Read more...

Original Article: BioLineRx Announces Regulatory Submission of Phase 3 Registrational Study for BL-8040 in Stem ...

NEXT ARTICLE

More From BioPortfolio on "BioLineRx Announces Regulatory Submission of Phase 3 Registrational Study for BL-8040 in Stem ..."

Advertisement
Quick Search
Advertisement
Advertisement